The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
Recruiting now NCT07278609
Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · for 60 and older · All sexes
What this study is about
The goal of this prospective observational quality improvement study is to determine if a physician tool, MedSafer, combined with educational brochures for patients, can help to reduce the use of 'potentially inappropriate medications' (PIMs) in adults aged 60 and over with rheumatic conditions and polypharmacy (taking 5 or more regular medications). Researchers will follow participants during usual rheumatic disease care. They will compare the rate of PIM deprescribing (stopping medications or reducing the dose) before and after the introduction of the following interventions: * MedSafer reports provided to treating physicians * EMPOWER consumer brochures provided to participants Participants will complete 4 study visits over 18-20 months during which researchers will collect information on medication changes, serious adverse events (emergency visits or hospitalizations), and quality of life.
Who can join (things the study team will check)
✅ You may be able to join if…
- Aged ≥60
- Followed by a rheumatologist at MUHC for an inflammatory arthritis (such as rheumatoid arthritis, psoriatic arthritis, spondyloarthritis), a systemic autoimmune rheumatic disease (such as systemic lupus erythematosus, inflammatory myositis, systemic sclerosis, antiphospholipid antibody syndrome, Sjogren syndrome, systemic vasculitis), or another chronic musculoskeletal or rheumatic condition (such as crystal arthritis and osteoarthritis)
- Currently taking ≥5 regular medications and ≥1 PIM
- Anticipated ongoing clinical follow-up in rheumatology at an interval of every 3-9 months
🚫 You may not be able to join if…
- Unable to provide informed consent
- Acute life-threatening illness or life expectancy <12 months
Where this trial is running
- Montreal General Hospital, McGill University Health Centre, Montreal, Quebec, Canada
Who to contact
Arielle Mendel, MD MSc · 5149341934 · arielle.mendel@mcgill.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07278609.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.